Gain Therapeutics GANX
NASDAQ GANX
$2.01 +0.03 (+1.26%)
At close: Aug 21, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Net Margin (QoQ) (2020 - 2023)

Gain Therapeutics (GANX) Net Margin (QoQ) (2020 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Gain Therapeutics 85.97 Mn 85.97 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 16.03 Mn
Jun 30, 2022 192,424.00
Mar 31, 2022 1.92 Mn
Dec 31, 2021 -946,454.00
Sep 30, 2021 -1.24 Mn
Jun 30, 2021 4.18 Mn
Mar 31, 2021 -3.52 Mn
Dec 31, 2020 57,095.00
Sep 30, 2020 -333,737.00
Jun 30, 2020 22,970.00